Where does Capitalbio Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Capitalbio Corporation ranks #9,466 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Capitalbio Corporation hold?

Capitalbio Corporation holds 33 US utility patents granted between 2015 and 2025, spanning 18 technology areas.

What is Capitalbio Corporation's Innovation Score?

Capitalbio Corporation has an Innovation Score of 45.0 out of 100 (top 24% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Capitalbio Corporation focus on?

Capitalbio Corporation's top technology area is B01L (Chemical OR Physical Laboratory Apparatus FOR General USE) with 16 patents, ranking #115 of 1,325 assignees active in that subclass. Grants appear in 18 CPC subclasses total.

Is Capitalbio Corporation's patent grant rate increasing or decreasing?

Capitalbio Corporation's recent grant velocity is -59% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Capitalbio Corporation's patents?

Capitalbio Corporation's patents average 20.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Capitalbio Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Capitalbio Corporation

USPTO PatentsView assignee record - 33 granted patents across 18 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B01L (Chemical OR Physical Laboratory Apparatus FOR General USE).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Capitalbio ranks #9,466 of 49,997 tracked US assignees by granted-patent volume, with 33 patents across 18 technology areas.

#9,466
of 49,997 US assignees by volume: Top 24%
by Innovation Score (45.0/100): 20.2
avg claims per patent: -59%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9466 · Foreign Corporation #9,466 · 33 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 33 grants
UPPER-Q #9,466/49,997
PHOTO-FINISH Brighterion
CPC-FOCUS B01L · 18 areas
INNOV-PAR 45.0/100
CLAIMS-DENSE 20.2 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -59% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Brighterion, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Capitalbio’s 45.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.2 pts (27%) Velocity 5.7 pts (13%) Breadth 15.0 pts (33%) Claim depth 12.1 pts (27%)

Qualcomm Incorporated · highest

85
Capitalbio · this assignee

45
China Medical… · near

45
Provenance Asset Group · near

45
Schluter Systems · near

45
Shire Human Genetic… · near

45
3D Lighting… · lowest

7

What this shows Capitalbio's Innovation Score is 45.0/100 (top 24% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Capitalbio?

Each dot is one of Capitalbio’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Capitalbio’s own 20.2 claims/patent is ABOVE the 14.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Capitalbio vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Capitalbio's grants concentrate

Capitalbio Corporation is a focused PatentsView assignee: 18 CPC subclasses with 48.5% of grants classified under B01L (Chemical OR Physical Laboratory Apparatus FOR General USE). Peak complete grant year is 2016 (5 grants) versus a trough of 1 in 2021. By volume, Capitalbio sits between Brighterion, Inc. and Clexio Biosciences Ltd..

Capitalbio's three-year grant acceleration

Capitalbio Corporation shows 6 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Brighterion

33
Britax Römer Kind…

33
Brooks Sports

33
C3 ai

33
Carl Zeiss X-ray…

33
Cell Signaling Te…

33
Center FOR Advanc…

33
Clexio Biosciences

33
Capitalbio ◀

33

What this shows Capitalbio holds 33 patents at rank #9,465, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Capitalbio

By rank, the assignees closest to #9,465 in granted patent volume.

Leaders in B01L (Chemical OR Physical Laboratory Apparatus FOR General USE)

Other assignees with the most granted patents in Capitalbio's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Capitalbio, neither rank-band nor same-CPC leaders (those blocks stay above). In B01L (Chemical OR Physical Laboratory Apparatus FOR General USE), Capitalbio ranks #115 of 1,325 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (45 here).

Schluter Systems L.P. 45 Provenance Asset Group LLC 45 China Medical University 45 Shire Human Genetic Therapies, Inc. 45

Capitalbio's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 24% higher than 76% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Capitalbio Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	4	12.1%
2016	5	15.2%
2017	5	15.2%
2018	4	12.1%
2019	4	12.1%
2020	2	6.1%
2021	1	3.0%
2022	3	9.1%
2023	3	9.1%
2025partial year	2	6.1%

Which technologies does Capitalbio Corporation patent most?

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 16

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 12

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 12

F16K - VALVES; TAPS; COCKS; ACTUATING-FLOATS; Devices FOR Venting OR Aerating 3

G06T - Image Data Processing OR Generation, IN General 3

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 2

B01F - Mixing, e.g. Dissolving, Emulsifying OR Dispersing 2

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

A61B - DIAGNOSIS; SURGERY; Identification 2

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 2

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 1

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 1

G06V - Image OR Video Recognition OR Understanding 1

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 1

Y10T - Technical Subjects Covered BY Former US Classification 1

Top 15 of 18 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Capitalbio Corporation's patent record in context - here's where to go next.

Capitalbio Corporation's lead technology class is B01L (Chemical OR Physical Laboratory Apparatus FOR General USE), 48.5% of its portfolio - see every assignee active in that class. Explore B01L
Ranked #9,466 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Capitalbio Corporation against Brighterion, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 45.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.